Skip to content
Since 1999, Joe Panetta has been President & CEO and a board member of Biocom California, the state’s advocate for the life sciences industry. […]
How a 2017 IRS tax law could bankrupt small American biotech companies in 2023 Read More »
Hispanic Heritage Month, from September 15 to October 15, serves as an important opportunity to remember and honor the contributions of the Hispanic community
Legislation to encourage innovation and protect patent holders should not be distorted into instruments for drug price controls, a high-profile group of former judges,
Top legal experts: Laws protecting IP aren’t tools for drug price controls Read More »
At least three-quarters of U.S. voters favor keeping the Bayh-Dole Act to back innovation and research, but are concerned that it may be “misused
Poll: U.S. voters support the Bayh-Dole Act, but fear its misuse by lawmakers Read More »
The Biotechnology Innovation Organization (BIO) is surveying biotech companies about their interactions with the Food and Drug Administration (FDA), with the goal of improving
BIO surveying biotech firms on how to improve communications with the FDA Read More »
Dubbed one of the most significant and inspiring pieces of legislation in the history of innovation and invention in the United States, the Bayh-Dole
Bayh-Dole Coalition awards 5 innovators for groundbreaking discoveries Read More »
Jennifer Camel-Toueg’s son was not getting better. “Alex, who is now 20 years old, was diagnosed with ulcerative colitis at 17,” recalled Camel-Toueg. “With
TrueTrials simplifies finding FDA-authorized cell therapy clinical trials Read More »
Drug price controls in the Inflation Reduction Act (IRA) harm the development of new drugs, according to Sept. 20 testimony in Congress from John
BIO Vice Chair John F. Crowley to Congress: IRA reduces access to innovative drugs Read More »
The Inflation Reduction Act (IRA) includes a misguided plan to control prices that will only result in costlier medicine and reduced access, lawmakers and
Why drug price controls ‘risk the future of investment’ in R&D Read More »
Kathleen Coviello is the New Jersey Economic Development Authority’s (NJEDA’s) Chief Economic Transformation Officer. In this role, she oversees the authority’s strategic sector, economic
New Jersey: a state for life sciences businesses of all sizes Read More »
